Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
37.11
-0.17 (-0.46%)
At close: Apr 28, 2026, 4:00 PM EDT
37.85
+0.74 (1.99%)
After-hours: Apr 28, 2026, 6:33 PM EDT
Vera Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Vera Therapeutics stock have an average target of 81.3, with a low estimate of 33 and a high estimate of 110. The average target predicts an increase of 119.08% from the current stock price of 37.11.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 11, 2026.
Analyst Ratings
The average analyst rating for Vera Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 5 | 5 | 5 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 11 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $88 | Hold → Buy | Upgrades | $88 | +137.13% | Mar 11, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $90 → $110 | Strong Buy | Maintains | $90 → $110 | +196.42% | Mar 2, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $48 → $66 | Strong Buy | Maintains | $48 → $66 | +77.85% | Dec 19, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $55 → $95 | Strong Buy | Maintains | $55 → $95 | +156.00% | Dec 19, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $99 → $96 | Buy | Maintains | $99 → $96 | +158.69% | Dec 19, 2025 |
Financial Forecast
Revenue This Year
47.13M
Revenue Next Year
269.81M
from 47.13M
Increased by 472.48%
EPS This Year
-5.34
from -4.66
EPS Next Year
-3.19
from -5.34
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 128.8M | 534.8M | ||||||
| Avg | 47.1M | 269.8M | ||||||
| Low | 10.0M | 127.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 1,034.6% | ||||||
| Avg | - | 472.5% | ||||||
| Low | - | 170.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.97 | -1.14 | ||||||
| Avg | -5.34 | -3.19 | ||||||
| Low | -6.59 | -4.54 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.